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Kong Special Administrative Region, 
People’s Republic of China reported 
74% would wear face masks in public, 
87% would make declarations at bor-
der crossings, and 88% would comply 
with quarantine policies (10).
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Near-Fatal Multiple 
Organ Dysfunction 
Syndrome Induced 
by Plasmodium 
malariae
To the Editor:  We report a case 
of Plasmodium malariae–related mul-
tiple organ dysfunction syndrome 
(MODS) in a healthy immunocom-
petent patient. Despite extensive in-
vestigation, P. malariae was the only 
pathogen identifi ed. The patient’s 
isolates had a combination of mutant 
alleles that could possibly explain the 
severity of the infection.
Five weeks after returning to 
France in November 2006 from Côte 
d’Ivoire, a 28-year-old French soldier 
was admitted to our surgical inten-
sive care unit (University Hospital, 
Rennes, France) because of fever and 
MODS of suspected infectious origin. 
The patient had stopped taking his 
doxycycline for antimalarial chemo-
prophylaxis 3 days before his admis-
sion. During those 3 days he began to 
experience myalgia, fatigue, nausea, 
and vomiting but no fever. He took no 
medication. He then became unable to 
move his lower legs and experienced 
paresthesia just before his condition 
rapidly deteriorated. He was found at 
home by the local Emergency Medical 
Service (EMS) in respiratory distress 
and shock and required immediate 
orotracheal intubation for mechanical 
ventilation. When admitted to the in-
tensive care unit, he had severe acute 
respiratory distress syndrome (PO2/
FiO2, 65 mm Hg; PCO2, 90 mm Hg; 
with positive end expiratory pressure 
of 12 cm H2O). Transthoracic echocar-
diography and pulmonary artery cath-
eterization showed severe global 
hypokinesia with a left ventricular 
ejection fraction of <10%, right ven-
tricular dilatation, and low pulmonary 
artery occlusion pressure. Blood tests 
showed disseminated intravascular 
coagulation with 30 × 109/L platelets, 
an international normalized ratio of 
3.54, an activated partial thrombo-
plastin time >180 s, and D-dimers at 
25.6 μg/mL. He had severe mixed aci-
dosis (pH 6.9 and arterial lactate 4.2 
mmol/L) and acute renal failure. Blood 
cultures were performed. A thin-blood 
fi lm showed Plasmodium spp. within 
the red blood cells (parasitemia 0.4%). 
Rapid fl uid resuscitation was carried 
out and epinephrine was given, along 
with intravenous quinine (1,000 mg 
over 4 h, then 1,500 mg/d) and broad-
spectrum antimicrobial drugs (cefo-
taxime and ofl oxacine). 
Massive acidosis developed (pH 
6.61; lactate 8.8 mmol/L). A brief 
cardiac arrest required chest com-
pressions and extracorporeal mem-
brane oxygenation (ECMO) after 
venoarterial femoral cannulation at 
the bedside. Continuous venovenous 
hemofi ltration was started. APACHE 
II and SAPS 2 scores were 38 and 93, 
respectively. Drotrecogin-alpha (acti-
vated) was given as a 96-h infusion.
Extensive microbiologic inves-
tigations included tests for common 
bacteria at usual sampling sites and 
tests for specifi c arboviruses, Lep-
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tospira spp., Rickettsia spp., and para-
sites other than Plasmodium spp. Re-
sults were negative. P. malariae was 
found in the thick-blood fi lm.
The patient’s cardiac and pulmo-
nary functions stabilized over the next 
week. Epinephrine and ECMO were 
stopped. Surgical exploration of exten-
sive lower-limb necrosis showed arteri-
al thrombosis and Serratia marcescens 
infection. Amputation was necessary of 
the right leg at the thigh and of the left 
lower leg after 1 month of hospitaliza-
tion. The patient was discharged from 
intensive care 90 days after hospital 
admission. One year later he was fully 
recovered and was using prostheses.
Almost all deaths from malaria 
are related to P. falciparum infection. 
We are unaware of previous reports of 
near-fatal imported P. malariae infec-
tion (1). Although we cannot defi nitive-
ly exclude bacterial co-infection, re-
sults were negative from blood cultures 
drawn before the fi rst antimicrobial 
drug dose and from all other micro-
biologic tests. To look for factors that 
might explain the unusual disease se-
verity, we conducted additional investi-
gations. The thick blood fi lm showed P. 
malariae trophozoites, schizonts, and 
gametocytes (285/μL). Rapid diagnos-
tic tests were positive for pan–Plasmo-
dium lactate dehydrogenase (pLDH) 
and aldolase but negative for histidine-
rich protein 2, which is specifi c for P. 
falciparum. Nested PCR with specifi c 
primers for P. falciparum and P. malar-
iae, followed by sequence analysis of 
the SSUrRNA gene, and nested PCR, 
followed by sequence analysis of the 
pLDH gene, were negative for P. fal-
ciparum, positive for P. malariae, and 
negative for P. knowlesi (2).
The patient gave written informed 
consent to tests for genetic polymor-
phisms associated with severe sepsis, 
coagulation disorders, and MODS (3). 
Several of these polymorphisms were 
found (Table). He had a mannose-bind-
ing lectin (MBL) haplotype associated 
with low MBL levels (2 variants in the 
promoter region [homozygous at –550 
and heterozygous at –221] and 1 in the 
fi rst exon [heterozygous for codon 54 
mutation]) (5). He was homozygous 
for 4 gene polymorphisms associated 
with higher susceptibility or severity 
of severe sepsis or both and ARDS: 
CD14, lymphotoxin alpha, TNF-alpha, 
IRAK-1, and IL-6 (6–9). Furthermore, 
he was homozygous for a PAI-1 variant 
associated with decreased fi brinolysis 
and a higher risk for amputation, skin 
grafting, and death in meningococcal 
disease and trauma (10). Of 11 pa-
tients with uncomplicated P. malariae 
whom we screened for these polymor-
phisms, none had such a combination 
of high-risk polymorphisms as did our 
patient. Thus, the genetic background 
of our patient may have contributed to 
the severity of P. malariae infection.
Despite extensive testing, we 
found no cause for this near-fatal case 
of MODS except P. malariae infec-
tion. An unusual combination of ge-
netic polymorphisms may explain the 
extreme severity of this classically 
mild infection.  
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Table. Results of genetic screening for single nucleotide polymorphisms known to be 
associated with sepsis severity in patient with Plasmodium malariae infection, France* 
Gene rs Wild type Heterozygous Homozygous 
Pathogen detection     
 TLR2 5743708 X   
 TLR2 5743704 X   
 TLR4 4986790 X   
 TLR5 5744168 X   
 CD14 2569190   X 
 MD-2 –1625C/G X   
 FcȖRIIa 1801274  X  
 MBL2 52 A/D X   
 MBL2 54 A/B  X  
 MBL2 57 A/C X   
 MBL2 –550 H/L   X 
 MBL2 –221 X/Y  X  
 MBL2 +4 P/Q X   
TLR signaling     
 IRAK1 1059703   X 
 TIRAP 8177374  X  
 IțB 3138053  X  
 IțB 2233406  X  
Inflammation     
 Lymphotoxin Į 909253   X 
 TNF Į 1800629   X 
 ACE 17236674   X 
 MIF 755622  X  
 IL-6 1800795   X 
 IL-10 1800896 X   
Coagulation     
 PAI-1 1799768   X 
 Factor V 6025 X    
*Except for MD-2 and MBL2, rs is the nomenclature used to describe the variants (initially described 
by den Dunnen and Antonarakis [4]). TLR, toll-like receptor; MBL2, mannose-binding lectin 2; IRAK-
1, interleulin-1 receptor-associated kinase; TIRAP, toll interleukin-1 receptor-associated protein; 
IțB:, inhibitor of Nf-țB; TNF, tumor necrosis factor; ACE, angiotensin-converting enzyme; MIF, 
macrophage migration inhibitory factor; IL, interleukin; PAI-1, plaminogen activator inhibitor-1.  
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Pulmonary 
Involvement and 
Leptospirosis, 
Greece 
To the Editor: Since the lep-
tospirosis outbreak associated with 
pulmonary hemorrhage in Nicaragua 
in 1995 (1), pulmonary manifesta-
tions of leptospirosis are often rec-
ognized in many countries; reported 
incidence has ranged from 20% to 
70% (2–4). The severe pulmonary 
form of leptospirosis is accompanied 
by pulmonary hemorrhage, which 
directly results in high death rates 
(2,5). In Greece (population 11 mil-
lion), leptospirosis cases in humans 
occur every year, usually from June 
to November (summer and autumn), 
with a peak in August. The annual in-
cidence rate of the disease is 3 cases 
per 1 million population (6). Clinical 
presentation varies from a fl u-like 
syndrome to Weil disease, which in-
cludes jaundice, renal failure, and 
hemorrhagic complications. Studies 
on leptospirosis in Greece have been 
limited, and no reports have focused 
on pulmonary involvement.
During 1998–2007, we tested 
samples from 650 patients with sus-
pected leptospirosis or hemorrhagic 
fever with renal syndrome (i.e., han-
tavirus infection). Various hospitals of 
northern Greece sent these samples to 
our laboratory (a World Health Orga-
nization Collaborating Center for Ref-
erence and Research on Arboviruses 
and Hemorrhagic Fever) for analysis. 
Because both diseases are endemic to 
Greece and have similar clinical, epi-
demiologic, and seasonal characteris-
tics (7), all samples sent to our labora-
tory for testing either for leptospirosis 
or for hantavirus infection are always 
tested for both (8).
Leptospirosis was confi rmed for 
123 patients, 10 (8.1%) of whom died 
(Table). For 72 case-patients, paired 
samples were available. A commercial 
ELISA (Leptospira IgG/IgM, Insti-
tute Virion/Serion GmbH, Würzburg, 
Germany) was used to detect immu-
noglobulin (Ig) G and IgM against 
Leptospira spp.. A nested PCR, which 
amplifi es a 289-bp fragment of the 
16S rDNA gene, was used to detect 
bacterial DNA (9). IgM concentrations 
>20 U/mL indicated acute infection. 
Samples with borderline results were 
tested in parallel with a second sample 
taken from the patient 1 week later. 
IgG concentrations were considered 
only for paired samples, and a case 
was considered as acute leptospiro-
sis when a >4-fold titer rise of IgG, 
or IgG seroconversion, was detected. 
When samples were taken before the 
sixth day of illness, initial diagnosis 
was achieved by PCR. In 6 of 10 fa-
tal cases, leptospirosis was diagnosed 
only by PCR because antibodies were 
not detectable. Epidemiologic and 
clinical information for patients was 
collected from chart review, following 
a protocol approved by the medical 
school review board.
All 123 patients resided in north-
ern Greece. Most (82.1%) were male; 
patients were 6–83 years of age (me-
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